Prostate Cancer Clinical Trials in Miami

Showing 81-100 of 136 trials

Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer

NCT05773703

Exploratory study in adult males with metastatic prostate cancer intended to characterize the pharmacokinetics and biodistribution of PSMA-Targeted \[In-111\]-Labeled Trillium Compounds with and without the cytoprotective agent PTI-122. Up to 36 eligible subjects will be enrolled. Additional subjects may be enrolled if there is insufficient data for evaluation, for example if the original study subjects do not complete required imaging studies for reasons unrelated to adverse events. Up to four PSMA-Targeted \[In-111\]-Labeled Trillium Compounds will be evaluated. Each compound will be evaluated first without the cytoprotective agent, PTI-122, then the \[In-111\]-labeled Trillium Compound may be co-administered with PTI-122.

Prostate Cancer

Ratio Therapeutics, Inc.23 participantsStarted Dec 2022

Miami, Florida, United States • Glen Burnie, Maryland, United States • Omaha, Nebraska, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

NCT00849290

This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)

Metastatic Androgen Independent Prostate Cancer

Dendreon113 participantsStarted Apr 2004

Los Angeles, California, United States • Los Angeles, California, United States • Sacramento, California, United States +55 more locations

Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Prostate Cancer Trials in Other Cities

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

Telomere Associated Variables (TAVs) in Prostate Cancer

TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Radiation Therapy in Treating Patients With Prostate Cancer

A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

Other Conditions in Miami